stage

Documents about stage

• Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma#154639ClinicalTrials.gov
• Efficacy & Safety for LN144 With Pembrolizumab With High Risk Stage IIIb-dResectable Melanoma#158210ClinicalTrials.gov
• MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by Surgery#300301ClinicalTrials.gov
• Vaccine Therapy With or Without Sargramostim in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma#287394ClinicalTrials.gov
• Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial#249598ClinicalTrials.gov
• Larval rearing of the hermit crab Pagurus comptus from the Beagle Channel#129517DataCite
• Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer#18621ClinicalTrials.gov
• Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer#143540ClinicalTrials.gov
• Metformin and Omega-3 Fatty Acids in Woman With a History of Early Stage Breast Cancer#329485ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Stage III-IV or Recurrent Ovarian Cancer#356532ClinicalTrials.gov
• Bevacizumab and Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma#208468ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With HER2-Negative Stage III-IV Breast Cancer#290842ClinicalTrials.gov
• Vemurafenib, Cobimetinib, Atezolizumab, and Tiragolumab in Treating Patients With High-Risk Stage III Melanoma#261526ClinicalTrials.gov
• Hypofractionated Radiation Therapy After Durvalumab and Chemotherapy for the Treatment of Stage IV Extensive Stage Small Cell Lung Cancer, CASPIAN-RT Trial#184851ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer#127672ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma#67660ClinicalTrials.gov
• Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer#181765ClinicalTrials.gov
• Metformin Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative Resection#148725ClinicalTrials.gov
• MUC1 Vaccine for Triple-negative Breast Cancer#172406ClinicalTrials.gov
• Neoadjuvant/Adjuvant Sintilimab, Nab-paclitaxel, and Gemcitabine for Resectable/Borderline Resectable Pancreatic Cancer#272364ClinicalTrials.gov
• Nivolumab and Brentuximab Vedotin in Treating Older Patients With Untreated Hodgkin Lymphoma#18598ClinicalTrials.gov
• Genetically Modified T-Cells Followed by Aldesleukin in Treating Patients With Stage III-IV Melanoma#136343ClinicalTrials.gov
• Talimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV Melanoma#279491ClinicalTrials.gov
• Metformin Hydrochloride in Treating Patients With Pancreatic Cancer That Can be Removed by Surgery#28573ClinicalTrials.gov
• Durvalumab and Tremelimumab Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Stage II-III Breast Cancer#238099ClinicalTrials.gov
• Pembrolizumab in Treating Patients With Bladder Cancer Undergoing Radical Cystectomy#148771ClinicalTrials.gov
• Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors#160345ClinicalTrials.gov
• OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission#356523ClinicalTrials.gov
• Pembrolizumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer#238130ClinicalTrials.gov
• Epacadostat Before Surgery in Treating Patients With Newly Diagnosed Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer#353274ClinicalTrials.gov
• Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer#136320ClinicalTrials.gov
• Edrecolomab in Treating Patients With Stage II Colon Cancer#152410ClinicalTrials.gov
• Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy#346934ClinicalTrials.gov
• Obinutuzumab and Lenalidomide in Treating Patients With Previously Untreated Stage II-IV Grade 1-3a Follicular Lymphoma#332747ClinicalTrials.gov
• Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors#67858ClinicalTrials.gov
• Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors#300270ClinicalTrials.gov
• Platinum-Based Chemotherapy and Durvalumab for the Treatment of Stage IIIB or IV Non-small Cell Lung Cancer#121343ClinicalTrials.gov
• Salvage Ovarian FANG™ Vaccine + Bevacizumab#127703ClinicalTrials.gov
• Vaccine Therapy and Resiquimod in Treating Patients With Stage II, Stage III, or Stage IV Melanoma That Has Been Completely Removed by Surgery#290840ClinicalTrials.gov
• Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery#136301ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma#184933ClinicalTrials.gov
• Immunotherapy Study for Patients With Stage IV Melanoma#287536ClinicalTrials.gov
• Neoadjuvant Chemoimmunotherapy in Stage IIIA- N2IIIB Non-small Cell Lung Cancer#123464ClinicalTrials.gov
• Vaccine Therapy With or Without Imiquimod in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma#249676ClinicalTrials.gov
• Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative#158196ClinicalTrials.gov
• Immunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell Carcinoma#127607ClinicalTrials.gov
• Weight Loss Referral for Healthier Survivorship in Obese Stage I-II Endometrial Cancer Survivors or Atypical Hyperplasia#136188ClinicalTrials.gov
• Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)#290969ClinicalTrials.gov
• Cryoablation, Atezolizumab/Nab-paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer#307441ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma#290848ClinicalTrials.gov